Cortexin vs Noopept
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Cortexin
Polypeptide nootropic extracted from the cortex of cattle or pigs, containing a mixture of low-molecular-weight neuropeptides (≤10 kDa). Registered pharmaceutical in Russia and widely used in Eastern European clinical medicine for stroke recovery, traumatic brain injury, cognitive decline, epilepsy, and cerebrovascular disease. Decades of Russian clinical literature support neuroprotective and neurorestorative effects.
Full profileNoopept
Dipeptide-derived nootropic developed in Russia and used across Eastern Europe as a cognitive enhancer and neuroprotective agent. Structurally related to piracetam but estimated to be approximately 1000× more potent by weight. Rapidly crosses the blood-brain barrier and is hydrolyzed to the endogenous neuropeptide cycloprolylglycine, which is proposed as its primary active metabolite.
Full profile| Cortexin | Noopept | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | cortexin polypeptide, cortexin-10, neuropeptide bioregulator, cortexin-5 | GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester, omberacetam, N-Phenylacetyl-L-Prolylglycine Ethyl Ester |
| Evidence | Research-stage | Research-stage |
| Dosing range | 5mg–20mg mg, daily IM injection for 10-day courses | 5mg–20mg mg, 1–3x daily oral or sublingual (8–12 week cycles) |
| Administration | Intramuscular injection | Oral (capsule/powder), Sublingual (dissolved under tongue), Intranasal |
| Key side effects | Injection site pain, Rare allergic reaction, Headache (transient), Mild dizziness | Headache (especially without choline supplementation), Irritability, Brain fog at high doses, Insomnia (if taken too late in day) |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: Cortexin — Intramuscular injection; Noopept — Oral (capsule/powder), Sublingual (dissolved under tongue), Intranasal.
- Frequency: Cortexin is typically daily IM injection for 10-day courses; Noopept is 1–3x daily oral or sublingual (8–12 week cycles).
How each works
Cortexin
Cortexin's multi-component neuropeptide mixture modulates neurotransmitter systems, improves cerebral blood flow, enhances neuroplasticity (BDNF upregulation), and exhibits antioxidant and anti-apoptotic activity in neuronal tissue. Russian stroke rehabilitation trials show improved neurological deficit scores and functional recovery with 10-day cortexin courses compared to standard care alone. The mechanism involves multiple parallel neuropeptide signaling pathways.
Noopept
Noopept (GVS-111) enhances AMPA-receptor function and increases expression of BDNF and NGF in the hippocampus and basal forebrain. Its active metabolite cycloprolylglycine acts as an endogenous neuropeptide with anxiolytic and cognition-enhancing properties. Russian clinical trials demonstrate cognitive improvement in subjects with cognitive impairment, with a better tolerability profile than piracetam at equipotent doses.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.